FierceBiotech

Watson Pharmaceuticals Announces New Research Showing RAPAFLO (silodosin) Improves Outcomes for Chronic Prostatitis

- RAPAFLO(R) demonstrated significant response in men with moderate to severe CP/CPPS - WASHINGTON, May 17, 2011 /PRNewswire/ -- New data presented today show that RAPAFLO(R) (silodosin) significantly ...
MM&M

DDR on DTC: RAPAFLO

BPH is one of those conditions that affects a large population and has physical symptomology that makes sufferers very uncomfortable. These facts make it a great condition for DTC. Unfortunately, ...
Monthly Prescribing Reference

Rapaflo available for benign prostatic hyperplasia (BPH)

RAPAFLO (Silodosin) 4mg, 8mg capsules by Watson Watson has launched Rapaflo (silodosin capsules), a selective alpha-1 adrenergic receptor antagonist, for the treatment of the signs and symptoms of ...
FierceBiotech

Watson Pharmaceuticals Receives US FDA Approval for RAPAFLO (silodosin) for the Treatment of Benign Prostatic Hyperplasia

CORONA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the U.S. Food and ...
Monthly Prescribing Reference

Rapaflo approved for BPH

RAPAFLO (Silodosin) 4mg, 8mg capsules by Watson The FDA has approved Rapaflo (silodosin, from Watson) for the treatment of benign prostatic hyperplasia (BPH). The FDA has approved Rapaflo (silodosin, ...
UPI

Rapaflo OK'd to treat enlarged prostate

WASHINGTON, Oct. 13 (UPI) -- The U.S. Food and Drug Administration has approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia. "Benign prostatic ...
Reuters

FDA approves Watson urology drug Rapaflo

NEW YORK, Oct 8 (Reuters) - U.S. health regulators have approved Watson Pharmaceuticals Inc's Rapaflo treatment for urination problems -- a condition known as benign prostatic hyperplasia (BPH), the ...
ABC News

Rapaflo Approved for Enlarged Prostate

Oct. 10 -- THURSDAY, Oct. 9 (HealthDay News) -- The once-daily alpha blocker Rapaflo (silodosin) has been approved by the U.S. Food and Drug Administration to treat benign prostatic hyperplasia (BPH), ...
MM&M

OPDP finds fault with Rapaflo website

A website indicating that Actavis’s alpha-blocker Rapaflo capsules can improve sleep and daytime productivity prompted an untitled letter from the FDA’s Office of Prescription Drug Promotion. The drug ...
FiercePharma

Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo® Patent

PARSIPPANY, N.J., June 19, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Kissei Pharmaceutical Co., LTD today confirmed that they have filed lawsuits against Sandoz Inc., Hetero USA, Inc., Hetero ...
Medindia

UPDATE: Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)

CORONA, Calif., Oct. 9 Watson Pharmaceuticals,Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced todaythat the U.S. Food and Drug Administration (FDA) has approved ...
Medindia

Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)

CORONA, Calif., Oct. 8 Watson Pharmaceuticals,Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced todaythat the U.S. Food and Drug Administration (FDA) has approved ...